Found 6 matching trials
SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer
PHASE1This is a single arm, open label study of SV-BR-1-GM, a targeted immunother...
Location
St. Joseph Heritage Healthcare
Allogeneic, Antigen-Presenting, GM-CSF-secreting, SV-BR-1-GM Whole Cell-Therapeutic Vaccine and Immunotherapy
PHASE1This is a prospective, single-center, phase 1 basket trial that will evalua...
Location
Multiple Locations
Combination Study of SV-BR-1-GM With Retifanlimab
PHASE1This is an open-label, phase I/II double arm study of the SV-BR-1-GM regime...
Location
Hoag Memorial Hospital Presbyterian
A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer
PHASE1This is an open-label Phase 1/2a study. Once the safety of the BC1 cell lin...
Location
Sarcoma Oncology Center
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
PHASE3This is a multicenter randomized, open label study to evaluate overall surv...
Location
Mayo Clinic-Comprehensive Cancer Center-Breast Clinic
Breast Cancer Vaccine in Combination With Pembrolizumab for Treatment of Persistent, Recurrent, or Metastatic Breast Cancer
PHASE1This phase I/II trial studies the side effects of a breast cancer vaccine (...
Location
Sidney Kimmel Cancer Center at Thomas Jefferson University